samedan logo
 
 
 
spacer
home > pmps > spring 2019 > finding the right solution
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Finding the Right Solution

Demand from healthcare providers for treatments that are both clinically effective and commercially sustainable continues to put pressure on the pharmaceutical industry’s bottom line. This, combined with increasingly stringent regulations, means drug companies need to redouble efforts to ensure the economic delivery of treatments, and they need to accomplish this without jeopardising the quality or safety of their products. Optimising the use of packaging is an important step towards achieving these goals.

An Evolving Business Environment

A major challenge facing firms is that pharma manufacturing processes and supply chains now need to accommodate both generic, bulk-produced products and newer small batch options. With production becoming increasingly based on demand and pharma companies reducing inventory for many drug lines, a more agile supply chain is essential to ensure operational efficiency.

Addressing these issues will require closer collaboration with packaging suppliers with a deep understanding of material science and a proven ability to create cost-effective, innovative, and robust designs. Offering tailored designs that provide mandatory levels of security at a price that lowers costs is just one part of the process − they also need to be delivered quickly and economically.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Kori Anderson is Honeywell’s General Manager for Healthcare Packaging. At this year’s Pharmapack Expo, Honeywell launched a new pharmaceutical packaging solution, Aclar Accel.
spacer
Kori Anderson
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

First cellularized collagen membrane implant to regenerate heart tissue in patients with ischemic heart disease

• 3P Biopharmaceuticals and Viscofan go ahead with this innovative project of regenerative medicine for cardiac use • Beginning of Phase I clinical trial in a group of 10 patients
More info >>

White Papers

Smaller, Smarter, Electronic, Connected: The Next Generation of Drug-Delivery Devices

Phillips-Medisize

An exciting trend in drug delivery is underway: the movement toward smaller, smarter, wirelessly connected electronic devices that allow patient-administered therapy. Inspired by the technological advancements driving the consumer electronics market, new methods for drug delivery show great promise for all stakeholders. Patients wishing to claim more autonomy over their drug regimens, caregivers and medical professionals wanting to more closely monitor drug compliance, health insurance organizations looking to keep costs down, and developers of pharmaceutical products interested in conducting better managed clinical trials can all benefit from these novel, next-generation technologies.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement